196 related articles for article (PubMed ID: 22177040)
41. [Value of jugulo-omohyoid lymph nodes in predicting lateral cervical occult metastasis in patients with papillary thyroid carcinoma].
An CM; Wang Y; Wang SX; Yin YL; Chen MQ; Xu ZG; Tang PZ; Li ZJ
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):207-210. PubMed ID: 28316221
[No Abstract] [Full Text] [Related]
42. Accuracy of preoperative MRI to assess lateral neck metastases in papillary thyroid carcinoma.
Renkonen S; Lindén R; Bäck L; Silén R; Mäenpää H; Tapiovaara L; Aro K
Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):3977-3983. PubMed ID: 28866793
[TBL] [Abstract][Full Text] [Related]
43. Pattern of anterolateral cervical lymph nodes involvement in papillary thyroid carcinoma.
Iqbal T; Zareen M; Iqbal A; Tahir F; Khan S; Ahmed Z
J Coll Physicians Surg Pak; 2009 Feb; 19(2):104-7. PubMed ID: 19208314
[TBL] [Abstract][Full Text] [Related]
44. Preoperative detection and predictors of level V lymph node metastasis in patients with papillary thyroid carcinoma.
Shim MJ; Roh JL; Gong G; Choi KJ; Lee JH; Cho SH; Nam SY; Kim SY
Br J Surg; 2013 Mar; 100(4):497-503. PubMed ID: 23254479
[TBL] [Abstract][Full Text] [Related]
45. The effect of surgeon experience on the detection of metastatic lymph nodes in the central compartment and the pathologic features of clinically unapparent metastatic lymph nodes: what are we missing when we don't perform a prophylactic dissection of central compartment lymph nodes in papillary thyroid cancer?
Scherl S; Mehra S; Clain J; Dos Reis LL; Persky M; Turk A; Wenig B; Husaini H; Urken ML
Thyroid; 2014 Aug; 24(8):1282-8. PubMed ID: 24787362
[TBL] [Abstract][Full Text] [Related]
46. Tumor location-dependent skip lateral cervical lymph node metastasis in papillary thyroid cancer.
Lee YS; Shin SC; Lim YS; Lee JC; Wang SG; Son SM; Kim IJ; Lee BJ
Head Neck; 2014 Jun; 36(6):887-91. PubMed ID: 23733708
[TBL] [Abstract][Full Text] [Related]
47. Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.
Nie X; Tan Z; Ge M
BMC Cancer; 2017 Oct; 17(1):702. PubMed ID: 29070029
[TBL] [Abstract][Full Text] [Related]
48. Roles of ultrasonography and computed tomography in the surgical management of cervical lymph node metastases in papillary thyroid carcinoma.
Lee DW; Ji YB; Sung ES; Park JS; Lee YJ; Park DW; Tae K
Eur J Surg Oncol; 2013 Feb; 39(2):191-6. PubMed ID: 22863305
[TBL] [Abstract][Full Text] [Related]
49. Clinicopathological significance of cancer-associated fibroblasts in papillary thyroid carcinoma: a predictive marker of cervical lymph node metastasis.
Cho JG; Byeon HK; Oh KH; Baek SK; Kwon SY; Jung KY; Woo JS
Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2355-2361. PubMed ID: 30019191
[TBL] [Abstract][Full Text] [Related]
50. [Risk factors of level Ⅵ lymph node metastasis in cN0 papillary thyroid carcinoma].
Ma N; Li JR; Guo HG
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(8):641-644. PubMed ID: 29871097
[No Abstract] [Full Text] [Related]
51. Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection.
Chung YS; Kim JY; Bae JS; Song BJ; Kim JS; Jeon HM; Jeong SS; Kim EK; Park WC
Thyroid; 2009 Mar; 19(3):241-6. PubMed ID: 19265495
[TBL] [Abstract][Full Text] [Related]
52. Incidence and Risk Factors for Occult Level 3 Lymph Node Metastases in Papillary Thyroid Cancer.
Fraser S; Zaidi N; Norlén O; Glover A; Kruijff S; Sywak M; Delbridge L; Sidhu SB
Ann Surg Oncol; 2016 Oct; 23(11):3587-3592. PubMed ID: 27188295
[TBL] [Abstract][Full Text] [Related]
53. [Clinical significance of lymphatic metastasis between sternocleidomastoid and sternohyoid muscle in papillary thyroid cancer].
Hao SL; Sun HQ; Liu XC; Chen HJ; Ning JY; Zheng GB; Wu GC; Song XC; Zheng HT
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Oct; 52(10):755-759. PubMed ID: 29050093
[No Abstract] [Full Text] [Related]
54. Occult contralateral central lymph node metastases in papillary thyroid carcinoma with unilateral lymph node metastasis in the lateral neck.
Koo BS; Choi EC; Park YH; Kim EH; Lim YC
J Am Coll Surg; 2010 Jun; 210(6):895-900. PubMed ID: 20510797
[TBL] [Abstract][Full Text] [Related]
55. [Risk factors for central neck lymph node metastases of papillary thyroid carcinoma].
Sun YS; Lyu HJ; Zhao YR; Zhang SS; Bai YX; Shi BY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):421-425. PubMed ID: 28635213
[No Abstract] [Full Text] [Related]
56. Identifying risk factors for metastasis to the level VII lymph node in papillary thyroid carcinoma patients.
Chen J; Zhang D; Fang L; He G; Gao L
BMC Surg; 2020 Jan; 20(1):13. PubMed ID: 31937295
[TBL] [Abstract][Full Text] [Related]
57. Regional metastatic pattern of papillary thyroid carcinoma.
Yüce I; Cağli S; Bayram A; Karasu F; Güney E
Eur Arch Otorhinolaryngol; 2010 Mar; 267(3):437-41. PubMed ID: 19585137
[TBL] [Abstract][Full Text] [Related]
58. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.
Koo BS; Choi EC; Yoon YH; Kim DH; Kim EH; Lim YC
Ann Surg; 2009 May; 249(5):840-4. PubMed ID: 19387316
[TBL] [Abstract][Full Text] [Related]
59. Sonographic features of primary tumor as independent predictive factors for lymph node metastasis in papillary thyroid carcinoma.
Wu Q; Li Y; Wang Y; Hu B
Clin Transl Oncol; 2015 Oct; 17(10):830-4. PubMed ID: 26041723
[TBL] [Abstract][Full Text] [Related]
60. Predictors of level II and Vb neck disease in metastatic papillary thyroid cancer.
Merdad M; Eskander A; Kroeker T; Freeman JL
Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1030-3. PubMed ID: 23165376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
